欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号FR/V/0245/001
药品名称Cevac IBird
活性成分
    • Infectious Bronchitis Virus 2.8 EID50/dose
剂型Oral lyophilisate
上市许可持有人CEVA Santé Animale
参考成员国 - 产品名称France (FR)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
    • Romania (RO)
    • Malta (MT)
    • Slovakia (SK)
    • Czechia (CZ)
    • Cyprus (CY)
    • Bulgaria (BG)
    • Hungary (HU)
      Cevac IBird vakcina A.U.V.
    • Estonia (EE)
      Cevac IBird
    • Lithuania (LT)
      CEVAC IBird, liofilizatas geriamajai suspensijai ruošti viščiukams
    • Latvia (LV)
      Cevac IBird
    • Poland (PL)
      Cevac IBird lyophilisate for suspension for chickens
    • Greece (GR)
    • Italy (IT)
    • Portugal (PT)
    • Spain (ES)
    • Austria (AT)
    • Ireland (IE)
      Cevac IBird
    • Luxembourg (LU)
    • Netherlands (NL)
    • Belgium (BE)
      Cevac IBird
    • Denmark (DK)
      Cevac Ibird
    • Germany (DE)
      CEVAC IBird
    • Croatia (HR)
    • Finland (FI)
    • Sweden (SE)
    • Slovenia (SI)
许可日期2013/05/29
最近更新日期2024/06/10
药物ATC编码
    • QI IMMUNOLOGICALS
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase